Annual Research Review: Attention‐deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions

SP Hinshaw, PT Nguyen, SM O'Grady… - Journal of Child …, 2022 - Wiley Online Library
Attention‐deficit/hyperactivity disorder (ADHD)–and its underlying behavioral dimensions of
inattention and hyperactivity–impulsivity–have been understudied in females. We first cover …

[HTML][HTML] Automatic autism spectrum disorder detection using artificial intelligence methods with MRI neuroimaging: A review

P Moridian, N Ghassemi, M Jafari… - Frontiers in Molecular …, 2022 - frontiersin.org
Autism spectrum disorder (ASD) is a brain condition characterized by diverse signs and
symptoms that appear in early childhood. ASD is also associated with communication …

Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study

S Cortese, M Song, LC Farhat, DK Yon, SW Lee… - Molecular …, 2023 - nature.com
Data on incidence, prevalence and burden of ADHD are crucial for clinicians, patients, and
stakeholders. We present the incidence, prevalence, and burden of ADHD globally and …

[HTML][HTML] ADHD diagnostic trends: increased recognition or overdiagnosis?

E Abdelnour, MO Jansen, JA Gold - Missouri medicine, 2022 - ncbi.nlm.nih.gov
Abstract The prevalence of Attention Deficit Hyperactivity Disorder (ADHD) has seen a
consistent rise in recent years. These numbers spark a debate over the reason for the …

[HTML][HTML] Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit/hyperactivity disorder: a substantive and …

CA Hartman, H Larsson, M Vos, A Bellato… - Neuroscience & …, 2023 - Elsevier
Abstract Knowledge on psychiatric comorbidity in adult ADHD is essential for prevention,
detection, and treatment of these conditions. This review (1) focuses on large studies (n> …

[HTML][HTML] A phase III, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of viloxazine extended-release capsules in adults with …

A Nasser, JT Hull, SA Chaturvedi, T Liranso, O Odebo… - CNS drugs, 2022 - Springer
Background and objective Attention-deficit/hyperactivity disorder is a neurodevelopmental
disorder that typically begins in childhood and often persists into adulthood. Recent phase III …

Towards equitable diagnoses for autism and attention-deficit/hyperactivity disorder across sexes and genders

MC Lai, HY Lin, SH Ameis - Current Opinion in Psychiatry, 2022 - journals.lww.com
Towards equitable diagnoses for autism and attention-deficit... : Current Opinion in Psychiatry
Towards equitable diagnoses for autism and attention-deficit/hyperactivity disorder across sexes …

[HTML][HTML] Treatment biomarkers for ADHD: Taking stock and moving forward

G Michelini, LJ Norman, P Shaw, SK Loo - Translational psychiatry, 2022 - nature.com
The development of treatment biomarkers for psychiatric disorders has been challenging,
particularly for heterogeneous neurodevelopmental conditions such as attention …

Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective

J Schein, LA Adler, A Childress, M Cloutier… - Journal of medical …, 2022 - Taylor & Francis
Objective To provide a comprehensive evaluation of the economic burden associated with
attention-deficit/hyperactivity disorder (ADHD) among children and adolescents from a US …

[HTML][HTML] Use of eye tracking to improve the identification of attention-deficit/hyperactivity disorder in children

DY Lee, Y Shin, RW Park, SM Cho, S Han, C Yoon… - Scientific Reports, 2023 - nature.com
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental
disorder of childhood. Although it requires timely detection and intervention, existing …